This is the worst sign for the U.S. stock market in 50 years

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

Jeffrey P. Julien net worth and biography

Jeffrey Julien Biography and Net Worth

VP of Raymond James

Jeff joined Raymond James Financial in 1983 and was named chief financial officer in 1987. He is responsible for all SEC reporting and financial management of the bank’s parent public company. Prior to joining Raymond James, he was a CPA with Price Waterhouse.

Jeff serves on the board of Raymond James Trust, was formerly licensed as a certified public accountant in the state of Florida and holds a Bachelor of Science in management science with a specialty in accounting from Duke University.

What is Jeffrey P. Julien's net worth?: The estimated net worth of Jeffrey P. Julien is at least $6.53 million as of June 5th, 2020. Mr. Julien owns 42,091 shares of Raymond James stock worth more than $6,526,210 as of December 22nd. This net worth approximation does not reflect any other investments that Mr. Julien may own. Learn More about Jeffrey P. Julien's net worth.
How old is Jeffrey P. Julien?: Mr. Julien is currently 62 years old. There are 4 older executives and no younger executives at Raymond James. Learn More on Jeffrey P. Julien's age.
How do I contact Jeffrey P. Julien?: The corporate mailing address for Mr. Julien and other Raymond James executives is 880 CARILLON PKWY, ST PETERSBURG FL, 33716. Raymond James can also be reached via phone at 727-567-1000 and via email at [email protected]. Learn More on Jeffrey P. Julien's contact information.
Has Jeffrey P. Julien been buying or selling shares of Raymond James?: Jeffrey P. Julien has not been actively trading shares of Raymond James in the last ninety days. Most recently, Jeffrey P. Julien sold 9,150 shares of the business's stock in a transaction on Friday, June 5th. The shares were sold at an average price of $81.58, for a transaction totalling $746,457.00. Following the completion of the sale, the vice president now directly owns 42,091 shares of the company's stock, valued at $3,433,783.78. Learn More on Jeffrey P. Julien's trading history.
Who are Raymond James' active insiders?: Raymond James' insider roster includes Bella Allaire (EVP), Paul Allison (CEO), James Bunn (Insider), John Carson, Jr. (President), Horace Carter (Insider), George Catanese (Insider), Scott Curtis (Insider), Jeffrey Dowdle (COO), Tashtego Elwyn (President & CEO), Thomas James (Chairman), Jeffrey Julien (VP), Jodi Perry (Insider), Steven Raney (CEO), Paul Reilly (Chair & CEO), and Jonathan Santelli (EVP). Learn More on Raymond James' active insiders.
Are insiders buying or selling shares of Raymond James?: In the last year, Raymond James insiders bought shares 1 times. They purchased a total of 879 shares worth more than $98,711.70. In the last year, insiders at the financial services provider sold shares 9 times. They sold a total of 130,421 shares worth more than $18,252,822.35. The most recent insider tranaction occured on December, 13th when insider Tashtego S Elwyn sold 10,000 shares worth more than $1,594,700.00. Insiders at Raymond James own 9.7% of the company. Learn More about insider trades at Raymond James.
Information on this page was last updated on 12/13/2024.

Jeffrey P. Julien Insider Trading History at Raymond James

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/5/2020	Sell	9,150	$81.58	$746,457.00	42,091
8/30/2019	Sell	15,756	$78.59	$1,238,264.04	39,591
4/29/2019	Sell	28,072	$90.99	$2,554,271.28	67,737
11/27/2017	Sell	11,925	$85.27	$1,016,844.75	45,465
2/13/2017	Sell	7,752	$77.75	$602,718.00	53,635
9/1/2016	Sell	18,600	$57.62	$1,071,732.00	46,407
8/12/2014	Sell	9,999	$51.72	$517,148.28

Jeffrey P. Julien Buying and Selling Activity at Raymond James

Raymond James Company Overview

Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties. The Capital Markets segment offers securities brokerage, trading, and research services to institutions with a focus on sale of the United States and Canadian equities and fixed income products; and manages and participates in underwritings, merger and acquisition services, and public finance activities. The Asset Management segment engages in the operations of Eagle, the Eagle Family of Funds, Cougar, the asset management operations of Raymond James & Associates, trust services of Raymond James Trust, and other fee-based asset management programs. The RJ Bank segment provides corporate loans, SBL, tax-exempt loans, and residential loans. The Other segment engages in private equity activities, including various direct and third party private equity investments; and private equity funds. Raymond James Financial, Inc. was founded in 1962 and is based in St. Petersburg, Florida.

Today's Range

Now: $155.05

$150.40

$155.23

50 Day Range

MA: $155.28

$130.16

$170.13

2 Week Range

Now: $155.05

$104.24

$171.38

Volume

3,879,977 shs

Average Volume

1,154,512 shs

Market Capitalization

$31.64 billion

P/E Ratio

15.97

Dividend Yield

1.19%

Beta

This is the worst sign for the U.S. stock market in 50 years

From Stansberry Research | Ad